Investing In Werewolf Therapeutics Inc (NASDAQ: HOWL) Does Not Require High Risk Tolerance
During the last session, Werewolf Therapeutics Inc (NASDAQ:HOWL)’s traded shares were 0.71 million, with the beta value of the company hitting 0.62. At the end